BLOOD-PRESSURE BEHAVIOR IN PATIENTS ON CHRONIC-HEMODIALYSIS (CH) TREATED WITH SUBCUTANEOUS AND ENDOVENOUS (EV) ERYTHROPOIETIN (EPO)

被引:0
作者
AMAYA, L [1 ]
BONELLI, CA [1 ]
PEREZ, N [1 ]
CHAMORRO, A [1 ]
OLMOS, Z [1 ]
BRUSCO, P [1 ]
VELAZQUEZ, J [1 ]
GUITIAN, N [1 ]
CASTRO, I [1 ]
机构
[1] CENT MIL HOSP, BUENOS AIRES, ARGENTINA
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1413 / 1413
页数:1
相关论文
共 50 条
[31]   NEGATIVE CORRELATION BETWEEN FASTING PLASMA-INSULIN AND AMBULATORY BLOOD-PRESSURE IN PATIENTS ON CHRONIC-HEMODIALYSIS [J].
WINNICKI, M ;
RYNKIEWICZ, A ;
NARKIEWICZ, K ;
BULLO, B ;
LICHODZIEJEWSKA, M ;
RUTKOWSKI, B ;
MANITIUS, A .
NEPHRON, 1993, 65 (03) :493-494
[32]   BLOOD-PRESSURE IN HEMODIALYSIS-PATIENTS DURING AMELIORATION OF ANEMIA WITH ERYTHROPOIETIN [J].
ABRAHAM, PA ;
MACRES, MG .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1991, 2 (04) :927-936
[33]   CORRECTION OF COAGULATION DISTURBANCES IN CHRONIC-HEMODIALYSIS PATIENTS TREATED WITH HUMAN RECOMBINANT ERYTHROPOIETIN(RHUEPO) [J].
CASATI, S ;
PASSERINI, P ;
MOIA, M ;
GRAZIANI, G ;
MANNUCCI, PM ;
PONTICELLI, C .
KIDNEY INTERNATIONAL, 1988, 33 (02) :622-622
[34]   THE INHIBITORY FACTORS OF HEMATOPOIESIS IN CHRONIC-HEMODIALYSIS PATIENTS TREATED WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN [J].
FUKUSHIMA, Y ;
NAKAMOTO, Y ;
MIURA, AB ;
MIYAGATA, S ;
TSUCHIDA, S .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 161 (03) :217-225
[35]   TRANSIENT INCREASE OF SERUM ERYTHROPOIETIN (EPO) AFTER SUBTOTAL PARATHYROIDECTOMY (PTX) IN PATIENTS (PTS) WITH CHRONIC-HEMODIALYSIS (HD) [J].
WASHIO, M ;
ISEKI, K ;
OH, Y ;
NAKAMOTO, M ;
FUJIMI, S ;
ONOYAMA, K ;
FUJISHIMA, M .
KIDNEY INTERNATIONAL, 1990, 37 (01) :285-285
[36]   RECOMBINANT ERYTHROPOIETIN (R-EPO) IMPROVES BRAIN-FUNCTION IN CHRONIC-HEMODIALYSIS (CHD) PATIENTS (PTS) [J].
NISSENSON, AR ;
MARSH, JI ;
BROWN, WS ;
SCHWEITZER, S ;
WOLCOTT, DL .
KIDNEY INTERNATIONAL, 1988, 33 (01) :232-232
[38]   VARIATIONS OF ARTERIAL-PRESSURE (BP) IN HEMODIALYSIS-PATIENTS (HD) TREATED WITH ERYTHROPOIETIN (EPO) [J].
ROMERO, M ;
CASALS, M ;
GABAS, J ;
ESCRIBA, JM ;
MARTINEZAMENOS, A ;
RAMA, H ;
SARRIAS, X .
KIDNEY INTERNATIONAL, 1993, 44 (06) :1490-1490
[39]   COMPARISON OF HEMODYNAMIC-EFFECTS OF BLOOD-TRANSFUSION AND ERYTHROPOIETIN IN CHRONIC-HEMODIALYSIS PATIENTS [J].
ISEKI, K ;
HORI, K ;
ONOYAMA, K ;
FUJIMI, S ;
FUJISHIMA, M .
KIDNEY INTERNATIONAL, 1989, 35 (01) :250-250
[40]   RESURGENCE OF BLOOD-TRANSFUSION (BT) THERAPY IN ERYTHROPOIETIN (EPO)-TREATED HEMODIALYSIS (HD) PATIENTS [J].
IFUDU, O ;
MACEY, LJ ;
FRIEDMAN, EA .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03) :455-455